Jonathan Van-Tam on COVID’s Next Phase
Former UK Deputy Chief Medical Officer discusses new protein-based vaccines, declining uptake, and the ongoing risks of COVID-19
False
Advertisement
Related Content
Development & Clinical
Small Molecules
Interviews
Musings from The Power List: Christine Allen
August 28, 2026
2 min read
Christine Allen believes AI will connect every stage of drug development, but only if it remains guided by human expertise
Biopharma
Technology & Manufacturing
The Hidden Complexity of Stability Storage
August 27, 2026
9 min read
Why preserving samples is a scientific, regulatory, and operational challenge – and what’s at risk when it goes wrong
Biopharma
Interviews
Business & Trends
Green Shoots, Gray Skies
August 26, 2026
9 min read
Jon Rees sees signs of recovery following biotech's post-pandemic funding reset, but there’s no going back to the “old normal”
Biopharma
Industry News
Development & Clinical
Phase III Success Marks Milestone for Personalized Cancer Vaccines
August 26, 2026
7 min read
Merck and Moderna report positive phase III results for intismeran in melanoma, as The Medicine Maker revisits how cancer vaccines work and the challenges still facing the field